NVR DU Pill - brown elliptical/oval
Generic Name: capmatinib
Pill with imprint NVR DU is Brown, Elliptical/Oval and has been identified as Tabrecta 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Tabrecta is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. Tabrecta 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR DU

Tabrecta
- Generic Name
- capmatinib
- Imprint
- NVR DU
- Strength
- 150 mg
- Color
- Brown
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0709
Related images for "NVR DU"
More about Tabrecta (capmatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.